Medication Management Reform Leader Katherine H. Capps to Lead Panel at Precision Medicine Leaders Summit

Share Article

Panel to Discuss Pharmacogenomic Testing in Comprehensive Medication Management Care Models

News Image
This Summit is a great opportunity for leaders in our field to share the latest findings on pharmacogenomics.

Katherine H. Capps, Co-founder and Executive Director of the Get the Medications Right Institute, will join leaders from the Get the Medications Right Institute on a panel at The Journal of Precision Medicine’s Precision Medicine Leaders Summit on Pharmacogenomics taking place virtually on Tuesday, October 19. The panel, “Improving Patient Outcomes Through the Integration of Pharmacogenomic Testing into Comprehensive Medication Management Care Models,” will discuss the value of precision medicine and pharmacogenomic testing services in CMM care models.

The panel will feature medication experts Ghada Elnashar, PharmD, MS, Medical Science Liaison, OneOme; Anthony P. Morreale, PharmD, MBA, BCPS, FASHP, Associate Chief Consultant, Clinical Pharmacy and Policy, Department of Veterans Affairs Pharmacy Benefits Management, VA Central Office; and Jacques Turgeon, BPharm, PhD, Chief Scientific Officer and Chief Executive Officer, TRHC Precision Pharmacotherapy, Research and Development Institute - the group recently published a report that explores the value of precision medicine and pharmacogenomic testing services in CMM care models.

The role of pharmacogenomics in the clinical setting is shifting from a reactive testing approach toward a preemptive model. The GTMRx Institute—and its membership of over 1,400 health care leaders—advocates for the broad adoption of comprehensive medication management (CMM), a more rational process of care in which physicians and clinical pharmacists work together to ensure that each medication is appropriate for the patient, effective for their medical condition, safe given the patient’s health status and other medications and able to be taken by the patient as intended. The Institute believes that companion and complementary diagnostics, used as part of the CMM process, may serve as an important tool to target correct therapies.

WHO: Virtual Event Open to the Public; FREE

WHAT: The role of pharmacogenomics in the clinical setting is shifting from a reactive testing approach toward a preemptive model. The goal of this panel is to educate health care professionals on the value of precision medicine and pharmacogenomic testing services in CMM care models.

WHEN: Tuesday, October 19 from 2:30pm - 3:10pm EST

WHERE: Register here: https://www.precisionmedicineleaderssummit.com/pharmacogenomics/

“Pharmacogenomic testing supports the delivery of more precise and appropriate therapies - and in combination with CMM, it allows for more personalized care,” said Capps. “This Summit is a great opportunity for leaders in our field to share the latest findings on pharmacogenomics and I’m honored to be part of advancing this important topic.”

About the Get the Medications Right™ Institute
The GTMRx Institute is a catalyst for change that brings critical stakeholders together, bound by the urgent need to get the medications right. We are physicians, pharmacists, nurses, patients, health IT innovators, drug and diagnostics companies, consumer groups, employers, payers—aligned to save lives and save money through comprehensive medication management. By showcasing evidence and innovation, we motivate practice transformation and push payment and policy reform. Together, we ACT to champion appropriate, effective, safe and precise use of medication and gene therapies. Learn more at gtmr.org.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Aimee Eichelberger
Superior PR
312-952-1528
Email >
Visit website